FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064609 [Registered on: 21/03/2024] Trial Registered Prospectively
Last Modified On: 22/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Balamoola rasayana for sciatica 
Scientific Title of Study   An open labelled randomized controlled clinical study to evaluate the effect of vardhamana balamoola rasayana in gridhrasi w.s.r to sciatica syndrome. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Anchumol joseph 
Designation  Pg scholar 
Affiliation  SDM AYURVEDA MEDICAL COLLEGE AND HOSPITAL UDUPI 
Address  Department of kayachikitsa and manasaroga SDM Ayurveda medical college and hospital kuthpady,udupi

Udupi
KARNATAKA
574118
India 
Phone  9446529173  
Fax    
Email  anchumoljoseph95@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Aniruddha 
Designation  Associate professor 
Affiliation  SDM Ayurveda medical college and hospital kuthpady,udupi 
Address  Department of P.G studies in kayachikitsa and manasaroga SDM ayurveda medical college kuthpady,udupi

Udupi
KARNATAKA
574118
India 
Phone  9446529173  
Fax    
Email  anisaralaya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Anchumol Joseph 
Designation  Pg scholar 
Affiliation  SDM ayurveda medical college and hospital kuthpady,udupi 
Address  Department of kayachikitsa and manasaroga SDM ayurveda medical college and hospital kuthpady,udupi

Udupi
KARNATAKA
574118
India 
Phone  9446529173  
Fax    
Email  anchumoljoseph95@gmail.com  
 
Source of Monetary or Material Support  
Shri dharmasthala manjunatheshwara college of ayurveda and hospital,kuthpady,udupi 
 
Primary Sponsor  
Name  Dr Anchumol Joseph  
Address  Pg scholar Department of kayachikitsa and manasaroga SDM ayurveda medical college and hospital,kuthpady,udupi 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anchumol Joseph   Shri dharmasthala manjunatheshwara college of ayurveda and hospital kuthpady udupi  Department of kayachikitsa and manasaroga,OPD-7,kayachikitsa kuthpady,udupi
Udupi
KARNATAKA 
9446529173

anchumoljoseph95@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL CLEARANCE COMMITTEE -HUMAN  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M543||Sciatica. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: lashuna rasayana, Reference: ashtanga hridaya rasayana adhyaya, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 48 Days, anupAna/sahapAna: Yes(details: milk), Additional Information: The study includes 1 day mridu virechana followed with 16 days lashuna rasayana course,1 day of mridu virechana after the rasayana course
2Intervention ArmDrugClassical(1) Medicine Name: BALAMOOLA RASAYANA, Reference: CHARAKA CHIKITSA STHANA RASAYANA ADHYAYA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 61 Days, anupAna/sahapAna: Yes(details: MILK), Additional Information: The study includes 1 day of mridu virechana followed with 30 days of balamoola rasayana course
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.Patients fulfilling the diagnostic criteria.
2.Patients with or without radiological evidence-MRI,CT of disc prolapse.
3.Patients with or without radiological evidence-MRI,CT of lumbar spondylosis.
4.Patients between the age groups of 18-70 years and of either sex. 
 
ExclusionCriteria 
Details  1.Patients with radiological evidence of fracture of vertebrae, congenital deformities and neoplasm of spine.
2.Pregnancy and lactating mother.
3.Evidence of osteoporosis with BMD less than -2.5
4.Had participated in any clinical trial within 3 months of screening. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
changes in the signs and symptoms of gridrasi.
changes in VAS scale
improvement on the basis of SLR test,bregards test, lasegues sign,bowstring test,femoral nerve stretch test,flip test
improvement in objective parameters like pain-greenough and fraser scoring method,neurological deficit assessment,assessment of functional ability-sugarbaker and barofsky clinical mobility scale,functional disability assessment-oswestry disability assessment questionnaire 
group A- 48 days
group B-61 days 
 
Secondary Outcome  
Outcome  TimePoints 
objective parameters  2 weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "32"
Final Enrollment numbers achieved (India)="32" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/04/2024 
Date of Study Completion (India) 26/08/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is an open labelled randomized controlled clinical study to evaluate the efficacy of balamoola rasayana and lashuna rasayana in vardhamana course in 30 patients diagnosed with gridhrasi/sciatica syndrome. The patients will be randomly divided into 2 groups of 15 each by adapting permuted block randomization method. Group A recruited subjects will be administered with vardhamana lashuna rasayana and group B recruited subjects will be administered with vardhamana balamoola rasayana .Total duration of study will be 48 days for group A and 61 days for group B. study will be conducted at Shri Dharmasthala Manjunatheshwara Ayurveda hospital kuthpady,udupi,karnataka,india. the primary outcome measures will be assesed based on changes in the signs and symptoms of gridrasi,changes in VAS scale, improvement on the basis of SLR test,bregards test, lasegues sign,bowstring test,femoral nerve stretch test,flip test and secondary outcome measures will be assessed based on the improvement in objective parameters like pain-greenough and fraser scoring method,neurological deficit assessment,assessment of functional ability-sugarbaker and barofsky clinical mobility scale,functional disability assessment-oswestry disability assessment questionnaire.Hence an effort has been planned through this clinical study evaluate the effect of vardhamana balamoola rasayana in gridhrasi. 
Close